Interestingly, the sensitivity of NK-92 treatment was greater in mice implanted with NLRP3 KO(−/−) HCC cells as compared with NLRP WT(+/+) HCC cells (n = 6; p < 0.05). Here, NLRP3 is linked to hepatocellular carcinoma.